Understanding how biological sex affects drug action in human pancreatic cells for diabetes
Genetic and molecular architecture of sex-specific drug response in human islets
This research explores how biological sex influences how certain drugs protect pancreatic cells in people with Type 2 diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-11131241 on NIH RePORTER |
What this research studies
Type 2 diabetes often involves problems with pancreatic cells, and we know that biological sex plays a role in how this disease develops, with men often experiencing more severe cell failure. This project aims to uncover the fundamental ways that sex, whether through genetics or hormones, shapes how these cells respond to a specific drug called bazedoxifene. We believe that both long-term genetic factors and short-term hormone effects contribute to these differences. By studying human pancreatic cells and using advanced computer analysis, we hope to understand why this drug might work differently for men and women.
Who could benefit from this research
Good fit: This foundational research does not involve direct patient participation, but future studies building on this work would likely focus on individuals with Type 2 diabetes.
Not a fit: Patients not interested in research focused on the biological differences in drug response for Type 2 diabetes may not find direct benefit from this specific project.
Why it matters
Potential benefit: If successful, this work could lead to more personalized treatments for Type 2 diabetes that consider a patient's biological sex, potentially improving drug effectiveness and protecting pancreatic cells.
How similar studies have performed: While sex differences in disease are recognized, the specific mechanisms of sex-specific drug response in human pancreatic islets are not yet well understood, making this a novel area of focus.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Mauvais-Jarvis, Franck — Tulane University of Louisiana
- Study coordinator: Mauvais-Jarvis, Franck
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.